BSPED2021

24 November 2021
08:50-09:00		Welcome and Introduction Chair(s):Anitha Kumaran (Southampton, UK)
09:00-10:15		CME Session 1 Chair(s):Anitha Kumaran (Southampton, UK) and James Law (Nottingham, UK)
09:00		Epidemiology of adrenal crisis in children R. Louise Rushworth (Sydney Clinical School, University of Notre Dame Australia, Sydney, Australia)
09:30		Kidney speaks - Interpreting kidney function tests in disorders of salt and water balance Detlef Bockenhauer (Leuven, Belgium)
10:00		Q&A
10:15-10:45		CME Case Presentations 1 Chair(s):Anitha Kumaran (Southampton, UK) and James Law (Nottingham, UK)
10:15	OC1.1	Severe hypercalcaemia in Williams-Beuren syndrome Karen Bell (RBHSC, Belfast, UK)
10:25	OC1.2	Two cases of functioning adrenocortical tumours secondary to TP53 variants Meera Shaunak (UCL Great Ormond Street Institute of Child Health, London, UK)
10:35		Q&A
10:45-11:00		Break
11:00-12:15		CME Session 2 Chair(s):Anitha Kumaran (Southampton, UK) and Charlotte Elder (Sheffield, UK)
11:00		Update in the recognition and management of adolescent PCOS Lourdes Ibanez (Sant Joan de Déu Hospital Barcelona, Barcelona, Spain)
11:30		Approach to a viralising girl in puberty Anna Nordenström (Karolinska University Hospital, Stockholm, Sweden)
12:00		Q&A
12:15-12:45		CME Case Presentations 2 Chair(s):Anitha Kumaran (Southampton, UK) and Charlotte Elder (Sheffield, UK)
12:15	OC2.1	Pitfalls and challenges in the diagnosis and management of Cushing’s disease in children: An interesting case Elspeth Ferguson (Sheffield, UK)
12:25	OC2.2	Two cases of McCune-Albright Syndrome with multisystem involvement Jananie Suntharesan (Alder Hey Children's Hospital, Liverpool, UK)
12:35		Q&A
12:45-12:55		CSAC Trainee Representative
12:55-13:55		Lunch
13:55-15:10		CME Session 3 Chair(s):Anitha Kumaran (Southampton, UK) and Senthil Senniappan (Liverpool, UK)
13:55		Controversies in management of neonatal hypoglycaemia Paul Thornton (Texas, USA)
14:25		Hypothalamic obesity post cancer treatment - optimising outcomes Robert Lustig (San Francisco, USA)
14:55		Q&A
15:10-15:15		CME Case Presentations 3 Chair(s):Anitha Kumaran (Southampton, UK) and Senthil Senniappan (Liverpool, UK)
15:10	OC3.1	Rapid-Onset Obesity, Hypothalamic Dysfunction, Hypoventilation, and Autonomic Dysregulation Syndrome (ROHHAD-NET): Case series & learning points Katherine Hawton (Bristol, UK)
15:15	OC3.2	Variable responses to sulfonylurea treatment in siblings from the same family with monogenic diabetes due to HNF1A mutation Natasha Franklin (Department of Paediatric Endocrinology, Bristol Children's Hospital, Bristol, UK)
15:20		Q&A
15:25-15:40		Break
15:40-16:40		CME Session 4 Chair(s):Anitha Kumaran (Southampton, UK) and Dr Sophia Sakka (London, UK)
15:40		Updating Diabetes care with advances in diabetes technology and digital health Tadej Battelino (University of Ljublijana, Ljubljana, Slovenia)
16:05		Hypoglycemia unawareness in type 1 diabetes – lessons learnt Rory McCrimmon (University of Dundee, Dundee, UK)
16:30		Q&A
16:40-16:55		CME Officer's Update
25 November 2021
07:45-08:45		Industry Sponsored Satellite Symposium
08:45-09:00		Break
09:00-09:10		Welcome from BSPED President and Chair Chair(s):Tabitha Randell (Nottingham, UK) & Senthil Senniappan (Liverpool, UK)
09:10-10:40		Endocrine Oral Comms 1 Chair(s):Hoong-Wei Gan (London, UK) and Justin Davies (Southampton, UK)
09:10	OC4.1	Dominant Mutations in CCDC141 are found by Whole Exome Sequencing to be a Common Cause of Self-Limited Delayed Puberty Sasha Howard (Queen Mary University of London and Barts Health NHS Trust, London, UK)
09:18	OC4.2	Pseudohypoparathyroidism type 1A and 1B: presentation, phenotypes and phenotype-genotype associations Philippa Prentice (North Middlesex Hospital, London, UK)
09:26	OC4.3	Growth hormone receptor 6Ω pseudoexon activation: a novel cause of severe growth hormone insensitivity Emily Cottrell (London, UK)
09:32	OC4.4	Does Inflammation Underpin Polycystic Ovary Syndrome (PCOS)? A Proteomic Approach to Novel Non-Invasive Biomarker and Pathway Discovery in Adolescent PCOS Harriet Gunn (London, UK)
09:40		Q&A
09:48	OC4.5	The biochemical evaluation of Metabolic Bone Disease of Prematurity (MBDP) in a high-risk population Gemma Watts (Queen Alexandra Hospital, Portsmouth, UK)
09:56	OC4.6	The management of adrenal cell carcinoma in the United Kingdom at a single centre: a 25 year experience Nicole Goff (London, UK)
10:04	OC4.7	The use of urinary steroid profiles in monitoring therapy in children with 21-hydroxylase deficiency – results from the CAH-UK cohort study Irina A Bacila (Sheffield, UK)
10:12	OC4.8	Destination outcome of 1151 gender variant young people presenting to paediatric endocrinology clinics in England and Wales since 2008 Gary Butler (London, UK)
10:20	OC4.9	The use of Liraglutide in the treatment of childhood obesity Louise Apperley (Alder Hey Children's Hospital, Liverpool, UK)
10:28		Q&A
09:10-10:40		Diabetes Symposium 1 Chair(s):Tabitha Randell (Nottingham, UK) and Amanda Peacock (Leeds, UK)
09:10		Low carbohydrate diets in type 1 diabetes Frances Hanson (Leeds Children’s Hospital, Leeds, UK)
09:30		Eating disorder risk in weight management Hiba Jebeile (University of Sydney, Sydney, Australia)
09:50		Low carbohydrate diets in type 2 diabetes David Unwin (RCGP Clinical Expert in Diabetes, Southport, UK)
10:10		Q&A
10:40-10:55		Break
10:55-11:55		Endocrine Symposium 1 Chair(s):Guftar Shaikh (Glasgow, UK) and Senthil Senniappan (Liverpool, UK)
10:55		Fertility preservation in boys Rod Mitchell (The University of Edinburgh , Edinburgh, UK)
11:15		Turner syndrome adolescence and beyond Joanne McManus (Medical Associates, Belfast, Ireland)
11:35		Q&A
10:55-11:55		Diabetes Symposium 2 Chair(s):Noina Abid (Belfast, Northern Ireland) and Neil Wright (Sheffield, UK)
10:55		Controversies in the management of DKA Rum Thomas (Sheffield Children's NHS Foundation Trust, Sheffield, UK)
11:15		Type 1 diabetes: moving into adulthood Partha Kar (Portsmouth Hospital, Portsmouth, UK)
11:35		Q&A
11:55-12:25		Endocrine Oral Comms 2 Chair(s):Renuka Dias (Birmingham, UK) and Pooja Sachdev (Nottingham, UK)
11:55	OC5.1	Evaluating UK Referral Criteria for Children with Short Stature in a Tertiary Paediatric Endocrinology Centre Gemma White (London, UK)
12:00	OC5.2	Evaluation of the discrepancy between free thyroxine (FT4) reference ranges and the impact on clinical investigation of central hypothyroidism Tony Hulse (Maidstone, UK) Tony HulseSusan Vickery (Maidstone, (Maidstone, UK)UK)
12:05	OC5.3	An Investigation Of Androgen-responsive Non-coding RNAs In Boys With Atypical Genitalia Without Genetic Variants in the Androgen Receptor (AR) Malika Alimussina (Glasgow, UK)
12:10	OC5.4	Virtual exercise sessions: An innovative way of promoting physical activity in children and young people with obesity Ellie Clarke (Liverpool, UK)
12:15	OC5.5	B-cell class switching in trans- and cis-gendered healthy young people is differentially influenced by sex hormones Hannah Peckham (London, UK)
12:20		Q&A
11:55-12:25		Diabetes Oral Comms 1 Chair(s):Melanie Kershaw (Birmingham, UK) and May Ng (Liverpool, UK)
11:55	OC7.1	Utility of glycated haemoglobin in assessing abnormal glucose homeostasis in children and adolescents with obesity undergoing oral glucose tolerance test Aayan Matan (Bristol Royal Hospital for Children, Bristol, UK)
12:00	OC7.2	Multi-Centre Service Evaluation of Presentation of Newly Diagnosed Type 1 Diabetes in Children in the U.K. During the COVID-19 Pandemic Ross McLean (University Hospital Wishaw, North Lanarkshire, UK)
12:05	OC7.3	Hybrid closed-loop in children and young people with type 1 diabetes improves glycaemic management and quality of life measures Nancy Katkat (Southport and Ormskirk Hospital, Southport , UK)
12:10	OC7.4	Patient experiences of the changes made to the Cardiff and Vale University Health Board Paediatric Diabetes service due to COVID-19 Megan Bone (Cardiff University, Cardiff, UK)
12:15	OC7.5	Screening for Eating Disorders in Young People with Type 1 Diabetes Nirit Braha (UCL Medical School, London, UK) Nirit BrahaRebecca Jacob (UCL Medical School, London, (UCL Medical School, London, UK)UK)
12:20		Q&A
12:25-12:40		Break
12:40-13:10		Industry Sponsored Expert Insights Session
12:40-13:10		Industry Sponsored Expert Insights Session
13:10-14:10		Lunch
14:10-14:40		Awards Session - James M Tanner Award Chair(s):Tabitha Randell (Nottingham, UK) and Senthil Senniappan (Liverpool, UK)
14:40-14:55		Break
14:55-15:55		Endocrine Symposium 2 Chair(s):Gary Butler (London, UK) and Bindu Avatapalle (Cardiff, UK)
14:55		GnRH analogues for gender dysphoria Sabine Hannema (Amsterdam, The Netherlands)
15:15		Using AMH and inhibin B assays in children and young people Sasha Howard (Queen Mary University of London and Barts Health NHS Trust, London, UK)
15:35		Q&A
14:55-15:55		Diabetes Symposium 3 Chair(s):Ritika Kapoor (London, UK) and Chizo Agwu (Birmingham, UK)
14:55		Early detection of neonatal diabetes David McGregor (Royal Devon and Exeter NHS Foundation Trust, Exeter, UK)
15:15		100 years of insulin - is it time for a UK Type 1 diabetes screening strategy? Rachel Besser (Oxford University Hospitals NHS Foundation Trust, Oxford, UK)
15:35		Q&A
15:55-16:10		Break
16:05-16:45		Personal Practice Session Chair(s):Mehul Dattani (London, UK) and Nikki Davis (Southampton, UK)
16:05		Medical management of T2DM in adolescents Elvira Isganaitis (Joslin Diabetes Centre, Boston, USA)
16:20		Management of thyroid nodules in children Andrew Bauer (Philadelphia, USA)
16:35		Q&A
16:10-16:40		Endocrine Oral Comms 3 Chair(s):Dinesh Giri (Bristol, UK) and Nils Krone (Sheffield, UK)
16:10	OC6.1	Novel dominant negative GH receptor variants provide important insights into GH receptor physiology Afiya Andrews (Centre for Endocrinology, William Harvey Research Institute, Barts and The London School of Medicine, Queen Mary University, London, UK)
16:15	OC6.2	Body composition in adults with genetically-confirmed Silver-Russell syndrome Oluwakemi Lokulo-Sodipe (University of Southampton, Southampton, UK)
16:20	OC6.3	Topiramate as a treatment option in managing obesity complicated by idiopathic intracranial hypertension and chronic migraine in children and adolescents Rhianwen Mathews (Department of Paediatric Endocrinology, Bristol Royal Hospital for Children, Bristol, UK)
16:25	OC6.4	Final height SDS of paediatric patients with ESRF that underwent renal transplantation Renuka Dias (Birmingham Women’s and Children’s NHS Foundation Trust , Birmingham, UK)
16:30	OC6.5	Highlighting POLE1 mutations as a cause of adrenal insufficiency Madhuvanthi Dhamodaran (Norfolk and Norwich University Hospitals, Norwich, UK) Madhuvanthi DhamodaranEmma Webb (Jenny Lind Children’s Hospital, Norwich, (Norfolk and Norwich University Hospitals, Norwich, UK)UK)
16:35		Q&A
16:40-16:55		Break
16:55-18:15		AGM
26 November 2021
09:00-09:30		Endocrine Nurses Business Meeting
09:30-11:00		Diabetes Symposium 4 Chair(s):Evelien Gevers (London, UK) and Fiona Campbell (Leeds, UK)
09:30		Optimising time in range using continuous glucose monitoring Pratik Choudhary (University of Leicester, Leicester, UK)
09:50		Real world use of the closed loop insulin delivery system Roman Hovorka (Cambridge, UK) Roman HovorkaJulia Ware (Cambridge, (Cambridge, UK)UK)
10:10		Personalising insulin therapy using smart pumps, pens and automated insulin delivery systems Julia Mader (Medical University of Graz, Graz, Austria)
10:30		Q&A
09:30-11:00		Endocrine Symposium 3 Chair(s):Lee Martin (London, UK) and Isabelle Sharratt (London, UK)
09:30		Non-medical prescribing: how can you make a difference to your service as a non-medical prescriber? Kate Davies (London South Bank University, London, UK)
09:50		Advanced nurse practice: what is advanced nurse practice? Stephen-Andrew Whyte (London South Bank University, London, UK)
10:10		Running a Paediatric Endocrine Nurse clinic: benefits and tips for success Peter Laing (Alder Hey Children's Hospital, Liverpool, UK)
10:30		Q&A
11:00-11:15		Break
11:15-12:45		Diabetes Oral Comms 2 Chair(s):Chris Moudiotis (Exeter, UK) and Rathi Prasad (London, UK)
11:15	OC8.1	Cystic fibrosis related diabetes (CFRD): could Cystic Fibrosis Transport Receptor (CFTR) modulators be the answer? Julie Park (Alder Hey Children's NHS Foundation Trust, Liverpool, UK)
11:23	OC8.2	The cost of diabetes school training was halved whilst training 25% more staff during COVID-19 using multi-media interactive care plans Louise Collins (Birmingham Women's and Children's Foundation Trust, Birmingham, UK) Louise CollinsJohn Pemberton (Birmingham, (Birmingham Women's and Children's Foundation Trust, Birmingham, UK)UK)
11:31	OC8.3	Nottingham’s Robin Hood approach to socioeconomic and ethnic disparities in paediatric diabetes Sarah Hill (Nottingham University Hospitals NHS Trust, Nottingham, UK) Sarah HillRabbi Swaby (University of Oxford, Oxford, (Nottingham University Hospitals NHS Trust, Nottingham, UK)UK)
11:39	OC8.4	Developing a clinical decision aid for paediatric diabetic ketoacidosis: the DKA Calculator Daniel Leach (Bristol Royal Hospital for Children, Bristol, UK)
11:47		Q&A
11:55	OC8.5	Permanent neonatal diabetes due to KCNJ11 mutation: early successful transition to Glibenclamide and stable glucose profile with multiple daily dosing Katherine Hawton (Bristol, UK)
12:03	OC8.6	Evaluation of the diabetes education app Rabbi Swaby (University of Oxford, Oxford, UK)
12:11	OC8.7	HENRY: High HbA1c service Evaluation 2016-2019: New “tipping point” in contactRequired for CYPwD John Pemberton (Birmingham, UK)
12:19	OC8.8	Barriers to uploading diabetes technology at home Elizabeth Boxel (Oxford University, Oxford, UK)
12:27	OC8.9	Virtual Sessions 'Cook and Count' for Young People with Type 1 Diabetes, Using PDSA Cycles, Meeting Young Peoples Wishes Kate Costello (Royal Free NHS Trust, London, UK) Kate CostelloVictoria Dublon (Royal Free NHS Trust, London, (Royal Free NHS Trust, London, UK)UK)
12:35		Q&A
11:15-12:15		Endocrine Oral Comms 4 Chair(s):Susan Sparrow (Cambridge, UK) and Karis Reyes (Cambridge, UK)
11:15	OC9.4	Changes in trends in Short Synacthen Test use over a decade - a single centre experience Callum Ross (The University of Sheffield, Sheffield, UK)
11:22	OC9.1	Variability in the diagnosis of growth hormone deficiency using dynamic tests. Time for robust pre-test criteria? Eva Zilber (Medical Sciences Division, University of Oxford, Oxford, UK)
11:29	OC9.2	Sex Steroid Priming for Growth Hormone Stimulation Testing – A Systematic Review Rod Mitchell (The University of Edinburgh , Edinburgh, UK)
11:36	OC9.3	Investigating paediatric weight management apps Sithara Ayamad (Centre for Endocrinology, William Harvey Research Institute, Queen Mary University of London, London, UK) Sithara AyamadMustafa Mohebi (Centre for Endocrinology, William Harvey Research Institute, Queen Mary University of London, London, (Centre for Endocrinology, William Harvey Research Institute, Queen Mary University of London, London, UK)UK)
11:43	OC9.5	Variability of advice and education for steroid sick day dosing in Duchenne Muscular Dystrophy: Results of a UK patient survey SC Wong (Department of Endocrinology and Diabetes, Evelina London Children's Hospital, London, UK)
11:50	OC9.6	'Think Adrenal': An innovative trust-wide safety and education programme designed for the care of patients with adrenal insufficiency Sally Tollerfield (Great Ormond Street Hospital, London, UK)
11:57		Q&A
12:15-12:45		Presentations from Previous Award Winners Chair(s):Christina Wei (London, UK) and Jo Blair (Liverpool, UK)
12:15		BSPED Research & Innovation Award Winner 2017 Claire Wood (Newcastle University, Newcastle upon Tyne, UK)
12:23		BSPED Research & Innovation Award Winner 2018 Toby Candler (Cardiff, UK)
12:31		BSPED Research & Innovation Award Winner 2018 Li Chan (Queen Mary University of London , London, UK)
12:39		Q&A
12:45-13:15		Lunch
13:15-13:45		Industry Sponsored Expert Insights Session
13:45-14:00		Break
14:00-15:30		Diabetes Symposium 5 Chair(s):Mars Skae (Manchester, UK) and Nicola Bridges (London, UK)
14:00		Effect of CFTR modulator therapy on cystic fibrosis-related diabetes Hal Scofield (University of Oklahoma Health Sciences Center, Oklahoma, USA)
14:20		Evaluation and Management of Genetic forms of Obesity Sadaf Farooqi (MRC Institute of Metabolic Science, Cambridge, UK)
14:40		Psychoeducation and changing behaviour: Knowing how doesn’t always mean action Deborah Christie (University College London, London, UK)
15:00		Q&A
14:00-15:30		Endocrine Symposium 4 Chair(s):Raja Padidela (Manchester, UK) and Renuka Ramakrishnan (Liverpool, UK)
14:00		Interpretation of abnormal thyroid function tests in children and adolescents Carla Moran (Beacon Hospital and University College Dublin, Dublin, Ireland)
14:20		Metabolic bone disease of prematurity: recognition, prevention and treatment Andrew Calabria (Children's Hospital of Philadelphia, Philadelphia, USA)
14:40		Newer treatment options for childhood obesity management Claudia Fox (University of Minnesota Medical School, Minnesota, USA)
15:00		Q&A
15:30-15:45		Break
15:45-16:00		BSPED 2021 Awards Session Chair(s):Sabah Alvi (Leeds, UK) and Helen Storr (London, UK)
16:00-16:15		Close of Meeting Chair(s):Senthil Senniappan (Liverpool, UK)

BSPED2021

24 November 2021

25 November 2021

26 November 2021